Effects of Nifedipine on Renal and Cardiovascular Responses to Neuropeptide Y in Anesthetized Rats

• Main Authors: Angela Bischoff, Martina Stickan-Verfürth, Martin C. Michel
• Format: Article
• Language: English
• Published: MDPI AG 2021-07-01
• Series: Molecules
• Subjects: neuropeptide Y; Y₁ receptor; Y₅ receptor; nifedipine; blood pressure; renal blood flow
• Online Access: https://www.mdpi.com/1420-3049/26/15/4460

Neuropeptide Y (NPY) acts via multiple receptor subtypes termed Y₁, Y₂ and Y₅. While Y₁ receptor-mediated effects, e.g., in the vasculature, are often sensitive to inhibitors of L-type Ca²⁺ channels such as nifedipine, little is known about the role of such channels in Y₅-mediated effects such as diuresis and natriuresis. Therefore, we explored whether nifedipine affects NPY-induced diuresis and natriuresis. After pre-treatment with nifedipine or vehicle, anesthetized rats received infusions or bolus injections of NPY. Infusion NPY (1 µg/kg/min) increased diuresis and natriuresis, and this was attenuated by intraperitoneal injection of nifedipine (3 µg/kg). Concomitant decreases in heart rate and reductions of renal blood flow were not attenuated by nifedipine. Bolus injections of NPY (0.3, 1, 3, 10 and 30 μg/kg) dose-dependently increased mean arterial pressure and renovascular vascular resistance; only the higher dose of nifedipine (100 μg/kg/min i.v.) moderately inhibited these effects. We conclude that Y₅-mediated diuresis and natriuresis are more sensitive to inhibition by nifedipine than Y₁-mediated renovascular effects. Whether this reflects a general sensitivity of Y₅ receptor-mediated responses or is specific for diuresis and natriuresis remains to be investigated.